Ursodeoxycholic acid for better recovery after retinal detachment surgery
Part of Eyes & vision clinical trials.
This trial tests if adding ursodeoxycholic acid (a bile acid medication) to standard surgery can protect the retina and improve vision after a retinal detachment. It's for people who need vitrectomy surgery and have a detached retina involving the macula.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for vitrectomy surgery for a retinal detachment.
- You have had a lens removed (aphakia) or have an artificial lens (pseudophakia).
- Your retinal detachment affects at least two quarters of your eye and involves the macula (central vision area).
- Your macula has been detached for 7 days or less when symptoms started.
- You have signed a consent form and have health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking a daily supplement called nicotinamide riboside after retinal detachment surgery can help the eye heal better and see more clearly. It is for people who had a specific type of retinal detachment and have already had cataract surgery.
This study looks at a specific surgical technique—peeling a thin retina layer—during surgery for a type of retinal detachment. It may help improve how well vision recovers when the detachment affects the macula and is more complex.
This study looks at how well surgery works for people with a specific type of detached retina (rhegmatogenous retinal detachment). It may help improve how doctors choose and manage treatment, based on what outcomes happen after repair.
This trial studies a “dropless” method (fewer post-surgery eye drops) after pars plana vitrectomy, a surgery used to repair a retinal detachment. It may help by improving comfort and simplifying recovery for people having this specific type of retinal detachment repair.
This Phase 2 trial tests an injection of topotecan into the eye after surgery for retinal detachment that keeps coming back due to scar tissue (proliferative vitreoretinopathy). It may help improve how the retina heals after difficult, repeat operations when vision is usually very guarded.
This trial compares two types of surgery for people with a retinal detachment who still have their natural lens (no prior cataract surgery). One group gets vitrectomy alone; the other gets vitrectomy plus the lens removed at the same time. The goal is to see which approach leads to better outcomes.
Hear when a new Retinal Detachment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.